Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models

Folashade Otegbeye(University Hospitals of Cleveland), David N. Wald(University Hospitals of Cleveland)

PLoS ONE

January 17, 2018

10.1371/journal.pone.0191358

Cited by 143

Related Papers

Sequential Single-Cell Transcriptional and Protein Marker Profiling Reveals TIGIT as a Marker of CD19 CAR-T Cell Dysfunction in Patients with Non-Hodgkin Lymphoma

|Cancer Discovery|2022|87